newsfilter
← Latest News
GlobeNewswire·

Impel NeuroPharma to Present at the Guggenheim Securities 3rd Annual Neuro/Immunology Conference

SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (NASDAQ:IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus o